One of the world’s largest vaccine makers is bringing its technology to the battle against the coronavirus spreading across China and the world.

GlaxoSmithKline Plc and the Coalition for Epidemic Preparedness Innovations said they would work to accelerate the creation of a vaccine. The goal is then to provide many vaccine doses rapidly, according to a statement Monday.

The project will rely on GSK’s adjuvant system, designed to enhance the body’s immune response and create a stronger and longer lasting protection against infection. Developing a preventive and confirming it’s safe and useful in humans could take 12 to 18 months,…